Guangdong Jiaying Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.00%

Guangdong Jiaying Pharmaceutical Co Ltd (002198) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 002198 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥12.29K

≈ $1.80K USD Cash + Short-term Investments

Total Assets

CN¥774.73 Million

≈ $113.37 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2023)

This chart shows how Guangdong Jiaying Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Guangdong Jiaying Pharmaceutical Co Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Guangdong Jiaying Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Guangdong Jiaying Pharmaceutical Co Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥12.29K	0.0%
Total Liquid Assets	CN¥12.29K	0.00%

Asset Resilience Insights

Limited Liquidity: Guangdong Jiaying Pharmaceutical Co Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangdong Jiaying Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangdong Jiaying Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Novartis AG SW:NOVN	Drug Manufacturers - General	10.04%
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Roche Holding AG SW:ROG	Drug Manufacturers - General	15.37%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHG:600436	Drug Manufacturers - General	17.40%
AstraZeneca PLC LSE:AZN	Drug Manufacturers - General	0.03%
Shandong Keyuan Pharmaceutical Co. Ltd. A SHE:301281	Drug Manufacturers - General	6.44%
Korean Drug Co. Ltd KQ:014570	Drug Manufacturers - General	12.77%
SANOFI CONS HEALTHC IND L NSE:SANOFICONR	Drug Manufacturers - General	0.07%

Annual Asset Resilience Ratio for Guangdong Jiaying Pharmaceutical Co Ltd (2014–2023)

The table below shows the annual Asset Resilience Ratio data for Guangdong Jiaying Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	23.66%	CN¥200.53 Million ≈ $29.34 Million	CN¥847.56 Million ≈ $124.03 Million	+17.72pp
2022-12-31	5.94%	CN¥50.26 Million ≈ $7.35 Million	CN¥846.65 Million ≈ $123.89 Million	+11.94pp
2019-12-31	-6.00%	CN¥-51.35 Million ≈ $-7.51 Million	CN¥855.94 Million ≈ $125.25 Million	-6.00pp
2018-12-31	0.00%	CN¥-12.83K ≈ $-1.88K	CN¥889.56 Million ≈ $130.17 Million	+0.04pp
2017-12-31	-0.04%	CN¥-326.08K ≈ $-47.72K	CN¥876.61 Million ≈ $128.28 Million	+0.38pp
2016-12-31	-0.42%	CN¥-4.58 Million ≈ $-670.90K	CN¥1.10 Billion ≈ $160.86 Million	--
2015-12-31	0.00%	CN¥0.00 ≈ $0.00	CN¥1.05 Billion ≈ $153.35 Million	--
2014-12-31	0.00%	CN¥0.00 ≈ $0.00	CN¥1.04 Billion ≈ $151.49 Million	--

pp = percentage points

About Guangdong Jiaying Pharmaceutical Co Ltd

SHE:002198 China Drug Manufacturers - General

Market Cap

$433.71 Million

CN¥2.96 Billion CNY

Market Cap Rank

#13301 Global

#4192 in China

Share Price

CN¥5.84

Change (1 day)

+0.00%

52-Week Range

CN¥5.84 - CN¥8.43

All Time High

CN¥14.97